Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Hypoparathyroidism Treatment Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028

Table of Content

  1. Preface

    • Market Definition and Scope

    • Market Segmentation

    • Key Research Objectives

    • Research Highlights

  2. Assumptions and Research Methodology

  3. Executive Summary : Global Hypoparathyroidism Treatment Market

  4. Market Overview

    • Introduction

      • Drug Class Definition

      • Industry Evolution / Developments

    • Overview

    • Market Dynamics

      • Drivers

      • Restraints

      • Opportunities

    • Global Hypoparathyroidism Treatment Market Analysis and Forecasts, 2016–2026

      • Market Revenue Projections (US$ Mn)

    • Porter’s Five Force Analysis

  5. Market Outlook

    • Pipeline Analysis

    • Reimbursement Scenario

    • Natpara – Brand Analysis

    • Disease Epidemiology

  6. Global Hypoparathyroidism Treatment Market Analysis and Forecasts, By Drug Class

    • Introduction & Definition

    • Key Findings / Developments

    • Market Value Forecast By Drug Class, 2016–2026

      • Parathyroid Hormone

        • Natpara

        • Others

      • Vitamin D Analogue

        • Vitamin D2

        • Vitamin D3

      • Calcium Supplements

    • Market Attractiveness By Drug Class

  7. Global Hypoparathyroidism Treatment Market Analysis and Forecasts, By Route of Administration

    • Introduction & Definition

    • Key Findings / Developments

    • Market Value Forecast By Route of Administration, 2016–2026

      • Oral

      • Parenteral

    • Market Attractiveness By Route of Administration

  8. Global Hypoparathyroidism Treatment Market Analysis and Forecasts, By Distribution Channels

    • Introduction & Definition

    • Key Findings / Developments

    • Market Value Forecast By Distribution Channels, 2016–2026

      • Hospital Pharmacy

      • Retail Pharmacy

      • Online sales

    • Market Attractiveness By Distribution Channels

  9. Global Hypoparathyroidism Treatment Market Analysis and Forecasts, By Region

    • Key Findings

    • Market Value Forecast By Region

      • North America

      • Europe

      • Asia Pacific

      • Latin America

      • Middle East & Africa

    • Market Attractiveness By Country/Region

  10. North America Hypoparathyroidism Treatment Market Analysis and Forecast

    • Introduction

      • Key Findings

    • Market Value Forecast By Drug Class, 2016–2026

      • Parathyroid Hormone

        • Natpara

        • Others

      • Vitamin D Analogue

        • Vitamin D2

        • Vitamin D3

      • Calcium Supplements

    • Market Value Forecast By Route of Administration, 2016–2026

      • Oral

      • Parenteral

    • Market Value Forecast By Distribution Channels, 2016–2026

      • Hospital Pharmacy

      • Retail Pharmacy

      • Online sales

    • Market Value Forecast By Country, 2016–2026

      • U.S.

      • Canada

    • Market Attractiveness Analysis

      • By Drug Class

      • By Route of Administration

      • By Distribution Channels

      • By Country

  11. Europe Hypoparathyroidism Treatment Market Analysis and Forecast

    • Introduction

      • Key Findings

    • Market Value Forecast By Drug Class, 2016–2026

      • Parathyroid Hormone

        • Natpara

        • Others

      • Vitamin D Analogue

        • Vitamin D2

        • Vitamin D3

      • Calcium Supplements

    • Market Value Forecast By Route of Administration, 2016–2026

      • Oral

      • Parenteral

    • Market Value Forecast By Distribution Channels, 2016–2026

      • Hospital Pharmacy

      • Retail Pharmacy

      • Online sales

    • Market Value Forecast By Country, 2016–2026

      • Germany

      • U.K.

      • France

      • Spain

      • Italy

      • Rest of Europe

    • Market Attractiveness Analysis

      • By Drug Class

      • By Route of Administration

      • By Distribution Channels

      • By Country

  12. Asia Pacific Hypoparathyroidism Treatment Market Analysis and Forecast

    • Introduction

      • Key Findings

    • Market Value Forecast By Drug Class, 2016–2026

      • Parathyroid Hormone

        • Natpara

        • Others

      • Vitamin D Analogue

        • Vitamin D2

        • Vitamin D3

      • Calcium Supplements

    • Market Value Forecast By Route of Administration, 2016–2026

      • Oral

      • Parenteral

    • Market Value Forecast By Distribution Channels, 2016–2026

      • Hospital Pharmacy

      • Retail Pharmacy

      • Online sales

    • Market Value Forecast By Country, 2016–2026

      • China

      • Japan

      • India

      • Australia & New Zealand

      • Rest of Asia Pacific

    • Market Attractiveness Analysis

      • By Drug Class

      • By Route of Administration

      • By Distribution Channels

      • By Country

  13. Latin America Hypoparathyroidism Treatment Market Analysis and Forecast

    • Introduction

      • Key Findings

    • Market Value Forecast By Drug Class, 2016–2026

      • Parathyroid Hormone

        • Natpara

        • Others

      • Vitamin D Analogue

        • Vitamin D2

        • Vitamin D3

      • Calcium Supplements

    • Market Value Forecast By Route of Administration, 2016–2026

      • Oral

      • Parenteral

    • Market Value Forecast By Distribution Channels, 2016–2026

      • Hospital Pharmacy

      • Retail Pharmacy

      • Online sales

    • Market Value Forecast By Country, 2016–2026

      • Brazil

      • Mexico

      • Rest of Latin America

    • Market Attractiveness Analysis

      • By Drug Class

      • By Route of Administration

      • By Distribution Channels

      • By Country

  14. Middle East & Africa Hypoparathyroidism Treatment Market Analysis and Forecast

    • Introduction

      • Key Findings

    • Market Value Forecast By Drug Class, 2016–2026

      • Parathyroid Hormone

        • Natpara

        • Others

      • Vitamin D Analogue

        • Vitamin D2

        • Vitamin D3

      • Calcium Supplements

    • Market Value Forecast By Route of Administration, 2016–2026

      • Oral

      • Parenteral

    • Market Value Forecast By Distribution Channels, 2016–2026

      • Hospital Pharmacy

      • Retail Pharmacy

      • Online sales

    • Market Value Forecast By Country, 2016–2026

      • GCC Countries

      • South Africa

      • Rest of Middle East & Africa

    • Market Attractiveness Analysis

      • By Drug Class

      • By Route of Administration

      • By Distribution Channels

      • By Country

  15. Competition Landscape

    • Market Player – Competition Matrix (By Tier and Size of companies)

    • Market Share Analysis By Company (2016)

    • Market Footprint Analysis

      • By Region

      • By Drug Class Type

    • Competitive Business Strategies

    • Company Profiles

      • Shire

      • F.Hoffmann-La Roche Ltd

      • EnteraBioLtd.

      • TevaPharmaceuticals

      • Sun Pharmaceutical Industries Inc.

      • AbbVie Corporation

      • Other Prominent Players

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote